TENOFOVIR Drug Patent Profile
✉ Email this page to a colleague
When do Tenofovir patents expire, and when can generic versions of Tenofovir launch?
Tenofovir is a drug marketed by Lupin, Apotex, Aurobindo Pharma, Chartwell, Chartwell Rx, Cipla, Hetero Labs Ltd Iii, Macleods Pharms, Micro Labs, Pharmobedient, Qilu, Reyoung, Strides Pharma, and Teva Pharms Usa. and is included in fifteen NDAs.
The generic ingredient in TENOFOVIR is tenofovir disoproxil fumarate. There are two drug master file entries for this compound. Sixteen suppliers are listed for this compound. Additional details are available on the tenofovir disoproxil fumarate profile page.
DrugPatentWatch® Litigation and Generic Entry Outlook for Tenofovir
A generic version of TENOFOVIR was approved as tenofovir disoproxil fumarate by TEVA PHARMS USA on March 18th, 2015.
AI Deep Research
Questions you can ask:
- What is the 5 year forecast for TENOFOVIR?
- What are the global sales for TENOFOVIR?
- What is Average Wholesale Price for TENOFOVIR?
Summary for TENOFOVIR
| US Patents: | 0 |
| Applicants: | 14 |
| NDAs: | 15 |
| Drug Prices: | Drug price information for TENOFOVIR |
| DailyMed Link: | TENOFOVIR at DailyMed |
US Patents and Regulatory Information for TENOFOVIR
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Lupin | TENOFOVIR ALAFENAMIDE | tenofovir alafenamide fumarate | TABLET;ORAL | 214226-001 | Mar 30, 2023 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Qilu | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate | TABLET;ORAL | 209498-001 | Mar 2, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| Teva Pharms Usa | TENOFOVIR DISOPROXIL FUMARATE | tenofovir disoproxil fumarate | TABLET;ORAL | 091612-003 | Jan 26, 2018 | AB | RX | No | No | ⤷ Start Trial | ⤷ Start Trial | ⤷ Start Trial | |||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
